These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 21670540)

  • 21. Rates of coronary intervention due to de novo significant atherosclerosis and cardiac death are very low in Korean patients with vasospastic angina: 36-month follow-up results of the Vasospastic Angina in the Catholic Medical Center (VA-CMC) registry.
    Shin DI; Baek SH; Seo SM; Koh YS; Choi YS; Kim DB; Her SH; Kim PJ; Lee JM; Kim HY; Yoo KD; Seung KB
    Circ J; 2012; 76(11):2681-9. PubMed ID: 22878408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasospastic angina: A literature review of current evidence.
    Picard F; Sayah N; Spagnoli V; Adjedj J; Varenne O
    Arch Cardiovasc Dis; 2019 Jan; 112(1):44-55. PubMed ID: 30197243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of vasomotion type on prognosis of coronary artery spasm induced by acetylcholine provocation test of left coronary artery.
    Lee EM; Choi MH; Seo HS; Kim HK; Kim NH; Choi CU; Kim JW; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    Atherosclerosis; 2017 Feb; 257():195-200. PubMed ID: 28012648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent nitrate therapy for prior myocardial infaraction does not induce rebound angina nor reduce cardiac events.
    Ishikawa K; Yamamoto T; Kanamasa K; Hayashi T; Takenaka T; Kimura A; Miyataka M; Yabushita H; Kitayama K;
    Intern Med; 2000 Dec; 39(12):1020-6. PubMed ID: 11197784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management and outcomes of non-ST elevation acute coronary syndromes in relation to previous use of antianginal therapies (from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).
    Kang JS; Goodman SG; Yan RT; Lopez-Sendon J; Pesant Y; Graham JJ; Fitchett D; Wong GC; Rose BF; Spencer FA; Yan AT;
    Am J Cardiol; 2013 Jul; 112(1):51-6. PubMed ID: 23582629
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gender differences in long-term clinical outcomes and prognostic factors in patients with vasospastic angina.
    Lee DH; Park TK; Seong CS; Gwag HB; Lim AY; Oh MS; Cho SW; Yang JH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Choi SH
    Int J Cardiol; 2017 Dec; 249():6-11. PubMed ID: 28592384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of cardio-protective therapy in patients with 5-FU (Fluorouracil)-associated coronary vasospasm.
    Zafar A; Drobni ZD; Lei M; Gongora CA; Quinaglia T; Lou UY; Mosarla R; Murphy SP; Jones-O'Connor M; Mahmood A; Hartmann S; Gilman HK; Weekes CD; Nipp R; Clark JR; Clark JW; Blaszkowsky LS; Tavares E; Neilan TG
    PLoS One; 2022; 17(4):e0265767. PubMed ID: 35390017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasospastic angina: Past, present, and future.
    He Z; Xu X; Zhao Q; Ding H; Wang DW
    Pharmacol Ther; 2023 Sep; 249():108500. PubMed ID: 37482097
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of statin therapy on long-term clinical outcomes of vasospastic angina without significant stenosis: A propensity-score matched analysis.
    Oh MS; Yang JH; Lee DH; Park TK; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Choi SH
    Int J Cardiol; 2016 Nov; 223():791-796. PubMed ID: 27573612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination of anti-angina drugs].
    Silber S
    Z Kardiol; 1989; 78 Suppl 2():160-74; discussion 188-9. PubMed ID: 2573981
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and long-term prognosis of vasospastic angina patients who survived out-of-hospital cardiac arrest: multicenter registry study of the Japanese Coronary Spasm Association.
    Takagi Y; Yasuda S; Tsunoda R; Ogata Y; Seki A; Sumiyoshi T; Matsui M; Goto T; Tanabe Y; Sueda S; Sato T; Ogawa S; Kubo N; Momomura S; Ogawa H; Shimokawa H;
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):295-302. PubMed ID: 21406685
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis.
    Lim AY; Park TK; Cho SW; Oh MS; Lee da H; Seong CS; Gwag HB; Yang JH; Song YB; Hahn JY; Choi JH; Lee SH; Gwon HC; Ahn J; Carriere KC; Choi SH
    Int J Cardiol; 2016 Oct; 221():161-6. PubMed ID: 27400315
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical efficacy of benidipine for vasospastic angina pectoris.
    Suzuki H; Yokoyama K; Akimoto Y; Daida H
    Arzneimittelforschung; 2007; 57(1):20-5. PubMed ID: 17341005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The 24-Month Prognosis of Patients With Positive or Intermediate Results in the Intracoronary Ergonovine Provocation Test.
    Shin DI; Baek SH; Her SH; Han SH; Ahn Y; Park KH; Kim DS; Yang TH; Choi DJ; Suh JW; Kwon HM; Lee BK; Gwon HC; Rha SW; Jo SH
    JACC Cardiovasc Interv; 2015 Jun; 8(7):914-23. PubMed ID: 26003026
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Systematic review on the short-term efficacy and safety of nicorandil for stable angina pectoris in comparison with those of β-blockers, nitrates and calcium antagonists].
    Hanai Y; Mita M; Hishinuma S; Shoji M
    Yakugaku Zasshi; 2010 Nov; 130(11):1549-63. PubMed ID: 21048416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Outcome of vasospastic angina with normal or near-normal coronary arteries (author's transl)].
    Bory M; Benichou M; Egré A; Djiane P; Serradimigni A
    Nouv Presse Med; 1982 Jun; 11(29):2195-9. PubMed ID: 6125931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential prognosis of vasospastic angina according to presentation with sudden cardiac arrest or not: Analysis of the Korean Health Insurance Review and Assessment Service.
    Park TK; Gwag HB; Park SJ; Park H; Kang D; Park J; Cho J; Chung CR; Jeon K; Suh GY; Guallar E; Cho J; Yang JH
    Int J Cardiol; 2018 Dec; 273():39-43. PubMed ID: 30282600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cardiac events in vasospastic angina: site and morphology of coronary artery spasm is related to the long-term prognosis of vasospastic angina].
    Mori F; Uchida T; Byun T; Tanino S; Imamura K; Oomori H; Nagashima M; Enta K; Tanaka M; Kasahara S; Hirosawa K
    J Cardiol; 1999 Apr; 33(4):191-9. PubMed ID: 10225201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina.
    Nihei T; Takahashi J; Hao K; Kikuchi Y; Odaka Y; Tsuburaya R; Nishimiya K; Matsumoto Y; Ito K; Miyata S; Sakata Y; Shimokawa H
    Eur Heart J; 2018 Mar; 39(11):952-959. PubMed ID: 29165549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and long-term prognosis of contemporary patients with vasospastic angina: Ethnic differences detected in an international comparative study.
    Sato K; Takahashi J; Odaka Y; Suda A; Sueda S; Teragawa H; Ishii K; Kiyooka T; Hirayama A; Sumiyoshi T; Tanabe Y; Kimura K; Kaikita K; Ong P; Sechtem U; Camici PG; Kaski JC; Crea F; Beltrame JF; Shimokawa H;
    Int J Cardiol; 2019 Sep; 291():13-18. PubMed ID: 30819587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.